Ciaran Lane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ciaran Lane has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Candice E. Crocker
Department of Psychiatry, Dalhousie University, Halifax, Canada
2 shared publications Karen Legg
Division of Neurology,Queen Elizabeth II Health Sciences Centre,Halifax,Nova Scotia,Canada
2 shared publicationsMallory Borden
Faculty of Health,Dalhousie University,Halifax,Nova Scotia,Canada
2 shared publicationsNeerav Goyal
Department of Otolaryngology, The Pennsylvania State University, Hershey, Pennsylvania, United States of America
2 shared publications- Aisha Ali
Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 3P5, Canada
1 shared publication Alice Lin
Department of Clinical Sciences, Kaiser Permanente School of Medicine, 4900 Sunset Boulevard 6th Floor, Los Angeles, CA 90027, USA
1 shared publication
Latest Publications
- Open Access
- 28 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6883
Neoadjuvant Treatment Approaches to Oral Cancer
Background/Objectives: The high prevalence of oral squamous cell carcinoma (OSCC) has driven the development of surgical and oncologic techniques to improve survival. Despite advancements in surgical technique and chemoradiation protocols, survival rates for locally advanced OSCC remain low due to high recurrence and metastasis. This has driven the exploration of neoadjuvant treatment protocols as a potential pathway towards improving organ-preserving resection, de-escalating adjuvant treatment, and improving overall and recurrence-free survival. Methods: This is a narrative review summarizing the current literature and ongoing trials on neoadjuvant treatment for OSCC. PubMed was searched using a snowballing technique to capture all relevant clinical trials. Results: 21 clinical trials were identified. Although neoadjuvant chemotherapy was associated with favorable pathologic outcomes, clinical trials demonstrated variable survival outcomes. In contrast, neoadjuvant immunotherapy for OSCC demonstrated improved pathologic responses and survival outcomes, with a low incidence of grade 3–4 adverse events. Conclusions: Neoadjuvant therapy in OSCC shows promise but does not yet constitute standard of care. Neoadjuvant immunotherapy has encouraging response rates and lower treatment-related toxicities in comparison to neoadjuvant chemotherapy. Although recent clinical trials have presented strong evidence to support the use of neoadjuvant immunotherapy in the treatment of locally advanced OSCC, further randomized trials are required to establish standardized neoadjuvant protocols and biomarkers to assess treatment response.
- 28 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6883
Open AccessNeoadjuvant Treatment Approaches to Oral Cancer
Background/Objectives: The high prevalence of oral squamous cell carcinoma (OSCC) has driven the development of surgical and oncologic techniques to improve survival. Despite advancements in surgical technique and chemoradiation protocols, survival rates for locally advanced OSCC remain low due to high recurrence and metastasis. This has driven the exploration of neoadjuvant treatment protocols as a potential pathway towards improving organ-preserving resection, de-escalating adjuvant treatment, and improving overall and recurrence-free survival. Methods: This is a narrative review summarizing the current literature and ongoing trials on neoadjuvant treatment for OSCC. PubMed was searched using a snowballing technique to capture all relevant clinical trials. Results: 21 clinical trials were identified. Although neoadjuvant chemotherapy was associated with favorable pathologic outcomes, clinical trials demonstrated variable survival outcomes. In contrast, neoadjuvant immunotherapy for OSCC demonstrated improved pathologic responses and survival outcomes, with a low incidence of grade 3–4 adverse events. Conclusions: Neoadjuvant therapy in OSCC shows promise but does not yet constitute standard of care. Neoadjuvant immunotherapy has encouraging response rates and lower treatment-related toxicities in comparison to neoadjuvant chemotherapy. Although recent clinical trials have presented strong evidence to support the use of neoadjuvant immunotherapy in the treatment of locally advanced OSCC, further randomized trials are required to establish standardized neoadjuvant protocols and biomarkers to assess treatment response.
- Open Access
- 9 December 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (6) , e70051
Otolaryngologist surgical preferences for orbital decompression in thyroid eye disease: A North American survey
Background: Orbital decompression is recommended for TED especially in the treatment of severe, refractory cases yet there are no clear guidelines regarding the optimal surgical approach. Previously conducted surveys assessed variations in the management of TED but only amongst ophthalmologists. Our study attempts to better characterize surgical and perioperative preferences amongst otolaryngologists in the management of TED.Methods: A survey was administered to the American Rhinologic Society and Canadian Society of Otolaryngology – Head and Neck Surgery via REDCap with 52 total respondents. Respondent demographic information and pre‐operative management, procedural specifics, and post‐operative management preferences were collected.Results: The majority of respondents practiced in a metropolitan (82.7%), academic setting (73.1%) and received subspecialty training in Rhinology & Skull Base Surgery (88.9%). Most elected for corticosteroids (63.5%) and medical management (69.2%) prior to orbital decompression but did not use any classification system (86.5%). Orbital decompression was most often done with ophthalmology collaboration (71.2%). Removal of two bony walls (55.8%) via medial wall (97.9%) and orbital floor (72.3%) removal was most preferred. Removal of one orbital fat aspect (60.6%) via the medial fat pad was most preferred. Combined bone and fat removal (59.6%) completed via an endoscopic approach (71.2% and 97.0%, respectively) was most common. Post‐operatively, most patients were not admitted (88.4%) with saline nasal rinses (92.3%) utilized by most respondents.Conclusions: This survey completed by otolaryngologists highlights several key distinctions in the preferred surgical approach during orbital decompression and the perioperative management of TED when compared to ophthalmologists and current recommendations.Level of evidence: Level 4.
- 9 December 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (6) , e70051
Open AccessOtolaryngologist surgical preferences for orbital decompression in thyroid eye disease: A North American survey
Background: Orbital decompression is recommended for TED especially in the treatment of severe, refractory cases yet there are no clear guidelines regarding the optimal surgical approach. Previously conducted surveys assessed variations in the management of TED but only amongst ophthalmologists. Our study attempts to better characterize surgical and perioperative preferences amongst otolaryngologists in the management of TED.Methods: A survey was administered to the American Rhinologic Society and Canadian Society of Otolaryngology – Head and Neck Surgery via REDCap with 52 total respondents. Respondent demographic information and pre‐operative management, procedural specifics, and post‐operative management preferences were collected.Results: The majority of respondents practiced in a metropolitan (82.7%), academic setting (73.1%) and received subspecialty training in Rhinology & Skull Base Surgery (88.9%). Most elected for corticosteroids (63.5%) and medical management (69.2%) prior to orbital decompression but did not use any classification system (86.5%). Orbital decompression was most often done with ophthalmology collaboration (71.2%). Removal of two bony walls (55.8%) via medial wall (97.9%) and orbital floor (72.3%) removal was most preferred. Removal of one orbital fat aspect (60.6%) via the medial fat pad was most preferred. Combined bone and fat removal (59.6%) completed via an endoscopic approach (71.2% and 97.0%, respectively) was most common. Post‐operatively, most patients were not admitted (88.4%) with saline nasal rinses (92.3%) utilized by most respondents.Conclusions: This survey completed by otolaryngologists highlights several key distinctions in the preferred surgical approach during orbital decompression and the perioperative management of TED when compared to ophthalmologists and current recommendations.Level of evidence: Level 4.
- 11 December 2023
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (2) , 104151
Commentary on “Advancing tracheoesophageal fistula repair techniques: Suggestions for future research”
- 11 December 2023
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (2) , 104151
Commentary on “Advancing tracheoesophageal fistula repair techniques: Suggestions for future research”
- 20 May 2023
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 56 (4) , 741-755
Scalp and Calvarium Reconstruction
- 20 May 2023
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 56 (4) , 741-755
Scalp and Calvarium Reconstruction
- 22 September 2022
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 19 (1) , 91.e1-91.e6
Geospatial analysis of hypospadias and cryptorchidism prevalence rates based on postal code in a Canadian province with stable population
- 22 September 2022
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 19 (1) , 91.e1-91.e6
Geospatial analysis of hypospadias and cryptorchidism prevalence rates based on postal code in a Canadian province with stable population
- 23 December 2021
- Published by Wiley in Head & Neck
- Vol. 44 (3) , 710-721
Selected functional outcomes in advanced oral cancer: Comparison of surgery alone versus surgery with postoperative radiotherapy
Background: Study objectives were to determine whether the addition of postoperative radiation (PORT) resulted in a decline in oral function relative to surgery alone and to describe the longitudinal course of oral function following treatment of advanced oral cancer.Methods: This was a 36‐month retrospectively analyzed observational cohort study of patients with stage III‐IV oral cancer. Prospectively collected, oral functional outcomes were acquired pretreatment and 3, 6, 12, 24, and 36 months post‐treatment.Results: One hundred and eighteen patients were included. Forty‐three patients treated with surgery alone were compared to 75 who received surgery with PORT. Mixed model analysis demonstrated the acute effect of PORT was associated with patient‐rated xerostomia (p < 0.001) and the late or persistent effect was associated with decreased clinician‐rated eating in public (p = 0.008), understandability of speech (p = 0.02), and normalcy of diet (p = 0.005) compared with surgery alone. There were no differences between surgery alone and PORT groups in clinician‐rated feeding tube dependence or patient‐rated speech handicap.Conclusions: The use of PORT was associated with a demonstrable decline in oral function in four of six outcomes measures relative to surgery alone.
- 23 December 2021
- Published by Wiley in Head & Neck
- Vol. 44 (3) , 710-721
Selected functional outcomes in advanced oral cancer: Comparison of surgery alone versus surgery with postoperative radiotherapy
Background: Study objectives were to determine whether the addition of postoperative radiation (PORT) resulted in a decline in oral function relative to surgery alone and to describe the longitudinal course of oral function following treatment of advanced oral cancer.Methods: This was a 36‐month retrospectively analyzed observational cohort study of patients with stage III‐IV oral cancer. Prospectively collected, oral functional outcomes were acquired pretreatment and 3, 6, 12, 24, and 36 months post‐treatment.Results: One hundred and eighteen patients were included. Forty‐three patients treated with surgery alone were compared to 75 who received surgery with PORT. Mixed model analysis demonstrated the acute effect of PORT was associated with patient‐rated xerostomia (p < 0.001) and the late or persistent effect was associated with decreased clinician‐rated eating in public (p = 0.008), understandability of speech (p = 0.02), and normalcy of diet (p = 0.005) compared with surgery alone. There were no differences between surgery alone and PORT groups in clinician‐rated feeding tube dependence or patient‐rated speech handicap.Conclusions: The use of PORT was associated with a demonstrable decline in oral function in four of six outcomes measures relative to surgery alone.
- Open Access
- 14 January 2020
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 5 (1) , 66-73
Systematic review and meta‐analysis of transoral laser microsurgery in hypopharyngeal carcinoma
Background: Transoral laser microsurgery has been suggested as an alternative treatment modality for hypopharyngeal carcinoma. The purpose of this study is to systematically review the oncologic and functional outcomes of patients with hypopharyngeal carcinoma when treated with primary transoral laser microsurgery.Methods: A comprehensive literature search was performed using PRISMA methodology on OVID MEDLINE and EMBASE. Meta‐analysis was completed for oncological outcomes.Results: Six studies reported quality of life outcomes five reported oncologic outcomes. A median of 95% (range 0.83‐0.98) patients achieving gastrostomy independence, a median of 3% (range 0%‐6%) were tracheostomy dependent, and a median of 97% (Range 0.89‐1.0) were able to preserve their larynx. Pooled five‐year overall survival was 54% (CI, 0.50‐0.58, I2 = 29%), pooled disease‐specific survival was 72% (CI, 0.68‐0.77, I2 = 46%), and pooled local control rate was 78% (CI, 0.72‐0.85, I2 = 69%).Conclusion: Systematic review supports improvements in functional outcomes and oncologic outcomes with transoral laser microsurgery.
- 14 January 2020
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 5 (1) , 66-73
Open AccessSystematic review and meta‐analysis of transoral laser microsurgery in hypopharyngeal carcinoma
Background: Transoral laser microsurgery has been suggested as an alternative treatment modality for hypopharyngeal carcinoma. The purpose of this study is to systematically review the oncologic and functional outcomes of patients with hypopharyngeal carcinoma when treated with primary transoral laser microsurgery.Methods: A comprehensive literature search was performed using PRISMA methodology on OVID MEDLINE and EMBASE. Meta‐analysis was completed for oncological outcomes.Results: Six studies reported quality of life outcomes five reported oncologic outcomes. A median of 95% (range 0.83‐0.98) patients achieving gastrostomy independence, a median of 3% (range 0%‐6%) were tracheostomy dependent, and a median of 97% (Range 0.89‐1.0) were able to preserve their larynx. Pooled five‐year overall survival was 54% (CI, 0.50‐0.58, I2 = 29%), pooled disease‐specific survival was 72% (CI, 0.68‐0.77, I2 = 46%), and pooled local control rate was 78% (CI, 0.72‐0.85, I2 = 69%).Conclusion: Systematic review supports improvements in functional outcomes and oncologic outcomes with transoral laser microsurgery.
- 21 May 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (3) , 782-789
Cochlear implant failures and reimplantation: A 30‐year analysis and literature review
Objectives/Hypothesis: The objectives of the study were to present an institutional experience with device failures and cochlear reimplantation rates over a 30‐year period and to perform a detailed literature review.Study Design: Retrospective institutional experience and literature review.Methods: A review of cochlear implant failures over a period of 30 years, between January 1988 and March 2017, at a single institution was conducted. Cochlear implant failures were calculated based on manufacturer, type of failure, and overall failure rate. Survival analysis was performed using Kaplan‐Meier curves. An electronic search of the PubMed, Web of Science, and EMBASE databases revealed 24 articles on the topic of cochlear device failure. Data on reimplantation and device failure rates were extracted from this literature review and analyzed.Results: A total of 804 cochlear implantations were reviewed from three manufacturers. The institutional reimplantation rate was 2.9% compared to the pooled rate of 6.0% calculated from the literature review. Medical failures accounted for 0.5% of the overall failures, device failures accounted for 1.6%, and inconclusive failures account for 0.7%. Survival analysis revealed a significant difference among manufacturers. An improved device failure rate was noted in the adult population (0.8%) as compared to the pediatric population (2.8%).Conclusions: This 30‐year review represents one of the longest series in the literature examining reimplantation, device failure, and medical failure rates. Cochlear implant survival varied by manufacturer and was significantly better in adult compared to pediatric patients.Level of Evidence: NALaryngoscope, 130:782–789, 2020
- 21 May 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (3) , 782-789
Cochlear implant failures and reimplantation: A 30‐year analysis and literature review
Objectives/Hypothesis: The objectives of the study were to present an institutional experience with device failures and cochlear reimplantation rates over a 30‐year period and to perform a detailed literature review.Study Design: Retrospective institutional experience and literature review.Methods: A review of cochlear implant failures over a period of 30 years, between January 1988 and March 2017, at a single institution was conducted. Cochlear implant failures were calculated based on manufacturer, type of failure, and overall failure rate. Survival analysis was performed using Kaplan‐Meier curves. An electronic search of the PubMed, Web of Science, and EMBASE databases revealed 24 articles on the topic of cochlear device failure. Data on reimplantation and device failure rates were extracted from this literature review and analyzed.Results: A total of 804 cochlear implantations were reviewed from three manufacturers. The institutional reimplantation rate was 2.9% compared to the pooled rate of 6.0% calculated from the literature review. Medical failures accounted for 0.5% of the overall failures, device failures accounted for 1.6%, and inconclusive failures account for 0.7%. Survival analysis revealed a significant difference among manufacturers. An improved device failure rate was noted in the adult population (0.8%) as compared to the pediatric population (2.8%).Conclusions: This 30‐year review represents one of the longest series in the literature examining reimplantation, device failure, and medical failure rates. Cochlear implant survival varied by manufacturer and was significantly better in adult compared to pediatric patients.Level of Evidence: NALaryngoscope, 130:782–789, 2020
- 25 September 2018
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 45 (6) , 723-724
Further Investigation of Screening for Anxiety and Depression in Epilepsy
- 25 September 2018
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 45 (6) , 723-724
Further Investigation of Screening for Anxiety and Depression in Epilepsy
- 8 January 2018
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 45 (2) , 144-149
Anxiety and Depression in Adult First Seizure Presentations
Objective:To define the prevalence of psychiatric symptoms of anxiety and depression in patients at the time of their first seizure presentation to a neurologist.Methods:Our pilot study uses a cohort approach with multimodal data (clinical, social, structural [3T magnetic resonance imaging], and functional [electroencephalogram]). We screened 105 patients referred to the Halifax First Seizure Clinic between 2014 and 2016 and 51 controls. All participants completed two screening questionnaires: Neurological Disorders Depression Inventory for Epilepsy and Generalized Anxiety Disorder 7-Item. After applying the exclusion criteria, the study population consisted of 57 patients with unprovoked first seizure and 31 controls. The prevalence of anxiety and depression was based on cutoff scores of >15 and >14 respectively.Results:Unprovoked first seizure patients showed higher prevalence of depression (33%) compared with control (6%) with an odds ratio (OR) of 2.75 (95% confidence interval [CI], 0.72-10.5). There was no significant difference in the prevalence of anxiety between control subjects (9.7%) and unprovoked first seizure patients (23%). Subcategory analysis conducted after diagnosis confirmation revealed significantly increased OR of depression in patients diagnosed with new-onset epilepsy (OR, 11.6; 95% CI, 2.1-64.0) and newly diagnosed epilepsy (OR, 20.0; 95% CI,2.2-181), but not first seizure only patients (OR, 2.2; 95% CI,0.28-17.6) compared with control.Conclusions:Our study supports a bidirectional relationship between the first seizure and depression. Prevalence rate of depression increased with duration of undiagnosed epilepsy at the time of first clinical assessment.
- 8 January 2018
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 45 (2) , 144-149
Anxiety and Depression in Adult First Seizure Presentations
Objective:To define the prevalence of psychiatric symptoms of anxiety and depression in patients at the time of their first seizure presentation to a neurologist.Methods:Our pilot study uses a cohort approach with multimodal data (clinical, social, structural [3T magnetic resonance imaging], and functional [electroencephalogram]). We screened 105 patients referred to the Halifax First Seizure Clinic between 2014 and 2016 and 51 controls. All participants completed two screening questionnaires: Neurological Disorders Depression Inventory for Epilepsy and Generalized Anxiety Disorder 7-Item. After applying the exclusion criteria, the study population consisted of 57 patients with unprovoked first seizure and 31 controls. The prevalence of anxiety and depression was based on cutoff scores of >15 and >14 respectively.Results:Unprovoked first seizure patients showed higher prevalence of depression (33%) compared with control (6%) with an odds ratio (OR) of 2.75 (95% confidence interval [CI], 0.72-10.5). There was no significant difference in the prevalence of anxiety between control subjects (9.7%) and unprovoked first seizure patients (23%). Subcategory analysis conducted after diagnosis confirmation revealed significantly increased OR of depression in patients diagnosed with new-onset epilepsy (OR, 11.6; 95% CI, 2.1-64.0) and newly diagnosed epilepsy (OR, 20.0; 95% CI,2.2-181), but not first seizure only patients (OR, 2.2; 95% CI,0.28-17.6) compared with control.Conclusions:Our study supports a bidirectional relationship between the first seizure and depression. Prevalence rate of depression increased with duration of undiagnosed epilepsy at the time of first clinical assessment.